Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 15, Issue 16
|
pp. 7997–8012
HYDIN mutation status as a potential predictor of immune checkpoint inhibitor efficacy in melanoma
Back to article
Figure 6
(6 of 6)
−
100%
+
Figure 6.
GSEA enrichment analysis between HYDIN-MUT and HYDIN-WT.
(
A
) KEGG enrichment analysis. (
B
) Reactome enrichment analysis. (
C
,
D
) GO-BP enrichment analysis.
